Results 131 to 140 of about 519,888 (169)
Some of the next articles are maybe not open access.
What's new: Management of venous leg ulcers: Approach to venous leg ulcers.
Journal of the American Academy of Dermatology, 2016Leg ulcerations are a common problem, with an estimated prevalence of 1% to 2% in the adult population. Venous leg ulcers are primarily treated in outpatient settings and often are managed by dermatologists. Recent advances in the diagnosis and treatment of leg ulcers combined with available evidence-based data will provide an update on this topic.
Alavi, Afsaneh +8 more
openaire +2 more sources
Chronic venous insufficiency and venous leg ulceration
Journal of the American Academy of Dermatology, 2001Venous ulcers are the most common form of leg ulcers. Venous disease has a significant impact on quality of life and work productivity. In addition, the costs associated with the long-term care of these chronic wounds are substantial. Although the exact pathogenic steps leading from venous hypertension to venous ulceration remain unclear, several ...
I C, Valencia +3 more
openaire +2 more sources
THE MANAGEMENT OF VENOUS ULCERS OF THE LEGS
Australasian Journal of Dermatology, 1991SummaryThe first step in the management of venous leg ulcers is correct diagnosis of the ulcer as venous in type. Calf pump dysfunction and resultant increased venous pressure are significant factors in the pathogenesis of venous leg ulcers. Good management is aimed at correcting these.
openaire +2 more sources
Compression Bandaging for Venous Leg Ulcers
Journal of Tissue Viability, 1995Effective compression heals leg ulcers and prevents their recurrence. Incorrect bandaging and poor technique are often features of leg ulcer management. A number of bandage systems are currently in use. Multi-layer systems appear to be more effective than single-layer systems.
openaire +3 more sources
What's new: Management of venous leg ulcers: Treating venous leg ulcers.
Journal of the American Academy of Dermatology, 2016Venous leg ulcers account for approximately 70% of all leg ulcers and affect 2.2 million Americans annually. After a comprehensive patient and wound assessment, compression therapy remains the cornerstone of standard care. Adjuvant care with topical or systemic agents is used for wounds that do not heal within 4 weeks.
Alavi, Afsaneh +8 more
openaire +2 more sources
Is this leg ulcer venous? Unusual aetiologies of lower leg ulcers
Journal of Wound Care, 2004The overwhelming majority of ulcers (95%) are vascular in origin. Most of these are venous (70%), and the rest are arterial (10%) or of mixed aetiology. The remaining 5% have other causes. This paper provides an overview of these rarer causes of leg ulceration, which can result in complex cases.
openaire +2 more sources
Compression and Venous Surgery for Venous Leg Ulcers
Clinics in Plastic Surgery, 2012This article reviews published data on the effects of surgery and compression in the treatment of venous ulcers and the best options for compression therapy. Randomized controlled studies reveal that surgery and compression have similar effectiveness in healing ulcers but surgery is more effective in preventing recurrence. Most leg ulcers have a venous
openaire +2 more sources
Venous Leg Ulcers: A Review of Published Assessment and Treatment Algorithms
Advances in Wound Care, 2022Stephanie Bernatchez, Dot Weir
exaly
Ugeskrift for laeger, 1997
The article summarizes current views regarding venous leg ulcers. Venous ulcers are resource-demanding and affect 1% of the population. Superficial and/or deep venous insufficiency is to be found combined with perforator insufficiency in the ankle are.
B, Hamilton Jakobsen, L, Danielsen
openaire +1 more source
The article summarizes current views regarding venous leg ulcers. Venous ulcers are resource-demanding and affect 1% of the population. Superficial and/or deep venous insufficiency is to be found combined with perforator insufficiency in the ankle are.
B, Hamilton Jakobsen, L, Danielsen
openaire +1 more source
Venous Leg Ulcers: Advanced Therapies and New Technologies
Biomedicines, 2021Agnieszka Owczarczyk-Saczonek
exaly